These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35018785)

  • 21. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
    Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study.
    Fan CY; Huang WY; Lin CS; Su YF; Lo CH; Tsao CC; Liu MY; Lin CL; Kao CH
    PLoS One; 2017; 12(4):e0175217. PubMed ID: 28384363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
    Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
    Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.
    Farioli A; Ottone M; Morganti AG; Compagnone G; Romani F; Cammelli S; Mattioli S; Violante FS
    Cancer Med; 2016 May; 5(5):950-9. PubMed ID: 26860323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second primary malignancy risk after radiotherapy in rectal cancer survivors.
    Wang TH; Liu CJ; Chao TF; Chen TJ; Hu YW
    World J Gastroenterol; 2018 Oct; 24(40):4586-4595. PubMed ID: 30386108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma.
    Neugut AI; Ahsan H; Robinson E; Ennis RD
    Cancer; 1997 Apr; 79(8):1600-4. PubMed ID: 9118045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
    Yang Y; Yang Y; Yan S
    Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
    Jia H; Li Q; Yuan J; Sun X; Wu Z
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
    Vuolukka K; Auvinen P; Palmgren JE; Aaltomaa S; Kataja V
    BMC Cancer; 2020 May; 20(1):453. PubMed ID: 32434560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer.
    Jin MC; Qian ZJ; Megwalu UC
    Anticancer Res; 2022 Mar; 42(3):1359-1365. PubMed ID: 35220228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy.
    Okajima K; Ishikawa K; Matsuura T; Tatebe H; Fujiwara K; Hiroi K; Hasegawa H; Nishimura Y
    Int J Clin Oncol; 2013 Dec; 18(6):1078-84. PubMed ID: 23179638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.
    Lönn S; Gilbert ES; Ron E; Smith SA; Stovall M; Curtis RE
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):464-74. PubMed ID: 20142245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.
    Hegemann NS; Schlesinger-Raab A; Ganswindt U; Hörl C; Combs SE; Hölzel D; Gschwend JE; Stief C; Belka C; Engel J
    Radiat Oncol; 2017 Jan; 12(1):2. PubMed ID: 28049538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M; Reis IM; Hamilton K
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second primary malignancies in cervical cancer and endometrial cancer survivors: a population-based analysis.
    Huang K; Xu L; Jia M; Liu W; Wang S; Han J; Li Y; Song Q; Fu Z
    Aging (Albany NY); 2022 May; 14(9):3836-3855. PubMed ID: 35507749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.